Successful development of methodology for detection of hapten-specific contact hypersensitivity (CHS) memory in swine.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
16
02
2019
accepted:
23
09
2019
entrez:
10
10
2019
pubmed:
10
10
2019
medline:
10
3
2020
Statut:
epublish
Résumé
Hapten contact hypersensitivity (CHS) elicits a well-documented inflammation response that can be used to illustrate training of immune cells through hapten-specific CHS memory. The education of hapten-specific memory T cells has been well-established, recent research in mice has expanded the "adaptive" characteristic of a memory response from solely a function of the adaptive immune system, to innate cells as well. To test whether similar responses are seen in a non-rodent model, we used hapten-specific CHS to measure the ear inflammation response of outbred pigs to dinitrofluorobenzene (DNFB), oxazolone (OXA), or vehicle controls. We adapted mouse innate memory literature protocols to the domestic pig model. Animals were challenged up to 32 days post initial sensitization exposure to the hapten, and specific ear swelling responses to this challenge were significant for 7, 21, and 32 days post-sensitization. We established hapten-specific CHS memory exists in a non-rodent model. We also developed a successful protocol for demonstrating these CHS responses in a porcine system.
Identifiants
pubmed: 31596901
doi: 10.1371/journal.pone.0223483
pii: PONE-D-19-04668
pmc: PMC6785115
doi:
Substances chimiques
Adjuvants, Immunologic
0
Haptens
0
Oxazolone
15646-46-5
Dinitrofluorobenzene
D241E059U6
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0223483Subventions
Organisme : NIH HHS
ID : R24 OD019813
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Science. 2011 Jan 7;331(6013):44-9
pubmed: 21212348
Immunity. 2015 Oct 20;43(4):634-45
pubmed: 26488815
Vet Pathol. 2000 Nov;37(6):565-80
pubmed: 11105946
Immunology. 2013 Sep;140(1):98-110
pubmed: 23659714
Lab Anim. 2018 Aug;52(4):402-412
pubmed: 29325489
Clin Exp Immunol. 2001 Sep;125(3):345-50
pubmed: 11531940
Nat Immunol. 2006 May;7(5):507-16
pubmed: 16617337
Nat Immunol. 2010 Dec;11(12):1127-35
pubmed: 20972432
Proc Natl Acad Sci U S A. 2014 May 20;111(20):7260-5
pubmed: 24799706
J Innate Immun. 2017;9(2):193-202
pubmed: 27988511
Nat Immunol. 2011 Jun;12(6):500-8
pubmed: 21739673
BMC Genomics. 2013 May 15;14:332
pubmed: 23676093
Toxins (Basel). 2009 Sep;1(1):25-36
pubmed: 22069530
J Immunol Res. 2014;2014:175265
pubmed: 24949488
Immunol Cell Biol. 2012 Sep;90(8):784-95
pubmed: 22290507
J Exp Med. 1996 Dec 1;184(6):2129-39
pubmed: 8976169
Clin Vaccine Immunol. 2014 Apr;21(4):534-45
pubmed: 24521784
Contact Dermatitis. 2002 Jan;46(1):1-5
pubmed: 11918579
Trends Microbiol. 2012 Jan;20(1):50-7
pubmed: 22153753
J Rare Dis Res Treat. 2017;2(3):1-6
pubmed: 29152615